The New York Times - Business:
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
Author: Rebecca Robbins and Reed Abelson
This post first appeared in The New York Times - Business. Read the original article.
